1. Total body water, extracellular fluid, total exchangeable potassium and total exchangeable sodium were measured by the multiple isotope-dilution technique in eight patients with congestive cardiac failure. Measurements were made on each patient while in failure and then again after treatment and recovery.
1. Total body water, extracellular fluid, total exchangeable potassium and total exchangeable sodium were measured by the multiple isotope-dilution technique in eight patients with congestive cardiac failure. Measurements were made on each patient while in failure and then again after treatment and recovery.
2. Compared with five control subjects in whom the same measurements were made, patients in failure had an excess of total body water, extracellular fluid and total exchangeable sodium, and had less total exchangeable potassium.
3. There was a decrease in total exchangeable sodium and an increase in total exchangeable potassium on recovery from congestive cardiac failure.
4. After treatment of cardiac failure, intracellular potassium increased and intracellular sodium was decreased.
5. The low total exchangeable potassium in cardiac failure is not simply due to loss of lean body mass.
Studies on electrolyte distribution in patients with congestive cardiac failure (CCF) have produced conflicting evidence. Patients in CCF with oedema have been shown to have high concentrations of exchangeable sodium even when this is expressed as mmoljkg body weight (Farber & Soberman, 1956; Birkenfeld, Leibman, O'Meara & Edelman, 1958) . In patients free of oedema, results have varied : Carroll, Gotterer & Altshuler (1965) found an increase in exchangeable sodium, whereas Lockey, Longmore, Ross & Sturridge (1966) and Oleson (1966) found no significant increase. Flear, Quinton, Carpenter, Domenet & Sivyer (1966) and Lockey et al. (1966) have reported a significant depletion of total exchangeable potassium in patients with cardiac failure.
In this study we have compared the distribution of sodium and potassium in a group of patients in heart failure with the distribution in the same patients after recovery. A control group of subjects who had not been in CCF was also studied.
METHODS
Measurements of total body water (TBW), extracellular fluid (ECF), total exchangeable sodium (Na.) and total exchangeable potassium (K e ) were made in eight patients with CCF; in four patients failure was secondary to cor-pulmonale (CP) and in the other four to rheumatic heart disease (RHD). Each patient was studied in failure and then again after treatment and recovery. Patients in CCF were oedematous and had raised jugular venous pressure. They were considered to have recovered when there was no clinical evidence of oedema or raised jugular venous pressure. All patients in CCF were treated with diuretics and potassium supplements. The same measurements were made in five control subjects who had not been in CCF.
TBW and sulphate space were measured simultaneously by using a solution containing approx. 100 }lCi of tritiated water and 40 }lCi of 35S injected intravenously. Uncorrected sulphate space was used as a measure of extracellular fluid. Plasma and urine samples were taken before injection. Pooled urine collections were obtained 0-2, 2-4, 4-6, 6-8 and 8-24 h after injection. Heparinized blood samples were obtained 2, 4, 6, 8 and 24 h after injection.
Measurements were made on the crude material for 35S content. 3 x 0·2 ml of each plasma sample and 3 x 0·5 ml of each urine sample were dispensed into counting vials. A 2 ml sample of Hyamine (75 g of Hyamine chloride +33 ml of methanol) was added to all samples and left at room temperature for 30 min before 10 ml of scintillator [6 g of 5-(4-biphenylyl)-2-(4-tert.-butylphenyl)-l-oxa-3,4-diazole (butyl-PBD) (CIBA) in I litre of toluene (AnalaR)] was added. The radioactivities of all samples were counted for 3-10 min in a Packard Tri-Carb Scintillation Spectrometer with conditions set to exclude the contributions from tritium so that only the 35S radioactivity was being detected. With 0·02 ml of 35S as an internal standard, the activity of each plasma and urine sample was calculated. Graphs were plotted of both plasma concentration and activity remaining in the body, in relation to time after injection. Both graphs were extrapolated to zero and the ECF was calculated as follows:
Activity in body at zero time ECF= PI . . asma concentration at zero time A 2 ml portion of each urine and plasma sample was freeze-dried and from the water driven off and accumulated as ice, 3 x 0·5 ml samples were dispensed into counting vials. The samples then contained only tritium, 35S having been left in the residue from the freeze-drying process. A 20 ml sample of aqueous scintillator [8 g of Butyl-PBD in 670 ml of toluene (AnalaR) plus 330 rhl of ethanol] was added to each vial and the radioactivities were counted with preselected tritium conditions. The radioactivity of each urine and plasma sample was calculated by using an internal standard of tritium. TBW was then calculated as follows:
Initial dose -Radioactivity lost in urine TBW = PI . (or uri . ) asma concentration or unne concentration
The quoted result of total body water is deduced from the mean of both plasma and urine measurements, except that urine concentrations at early equilibration times are ignored when they have clearly not reached equilibrium.
Na, and K, were measured by using approx. 100 }lCi of 24Na and 100}lCi of 42K injected intravenously. The method used is described by Veall & Vetter (1958) . Five plasma and five urine samples were collected at hourly intervals from 20 to 24 h after the injection, and the values for Na, and K, were taken as the average of the values obtained from these samples.
As the plasma counts for potassium were very small, only the urine values were used. Plasma Na and K were measured by flame photometry. Extracellular Na and K were calculated by multiplying the ECF volume by the plasma Na and K concentrations. Residual Na and K were calculated by subtracting extracellular Na and K from Na, and K, respectively.
The TBW values were checked by using Na, and K, and plasma Na and K values. Assuming there is no osmotic gradient across the cell membranes, the extracellular cation concentration must equal the intracellular cation concentration. Thus a value can be derived for total cation space, (Na e+ Ke)/(Plasma Na+K), which must reflect total body water.
Na, and K, were related to dry body weight (DBW = Wt-TBW) rather than to lean body mass as estimates of the latter are based on the assumption that water content of tissue is constant. Body weight was not used as changes in body water cause body weight to vary.
Significance values were calculated by a paired t test. Table 1 shows values for eight patients in CCF, four secondary to CP and four secondary to RHD. Each patient was studied in failure and then again after treatment and recovery from CCF. Table 2 shows values obtained in five in-patients who had not been in CCF.
RESULTS
Weight. The mean body weight fell from 55·9 kg in failure to 51·8 kg after recovery, 61·2 to 56·2 kg in CP and 50·5 to 47·3 kg in RHD.
Total body water (TBW). The mean TBW fell from 34·8 to 31·4 I after recovery, 38·6 to 34·71 in CP and 30·9 to 28·81 in RHD. The control group had a TBW of 41·51. When expressed as a percentage of body weight, however, TBW was 62'3% in CCF and 60·6% after recovery compared with 58'4% in the control group (calculated from Tables 1 and 2) .
Dry body weight (DBW).
There was no significant change in mean DBW after treatment of CCF.
Extracellular fluid (ECF). The mean ECF fell from 17·71 in failure to 14·61 after recovery. 19·1 to 15·6 I in CP and 16·2 to 13-9 I in RHD. The control group had an ECF of 15·2 I, Expressed as a percentage of body weight, ECF was 31'7% in CCF, 28·2% on recovery and 21'3% in the control group.
Intracellular fluid (ICF). The mean ICF fell from 17·3 I in failure to 16·0 I after recovery, 19·6 to 17·81 in CP and 15·0 to 14·21 in RHD. This change was not significant.
Total exchangeable sodium (Na e ) . The mean Na, fell from 3328 mmol in failure to 2889 mmol after recovery, 3793 to 3276 mmol in CP and 2862 to 2502 mmol in RHD. When Na, concentrations were related to DBW, it was found that the mean value for Nae/DBW fell from 167·8 mmol/kg in failure to 149·5 mmol/kg after recovery, 187·1 to 162·4 mmol/kg in CP and 148·6 to 136·6 mmol/kg in RHD.
Residual sodium (Res Na). The mean Res Na fell from 1051 mmol in failure to 790 mmol after recovery, Il21 to 938 mmol in CP and 981 to 642 mmol in RHD.
Total exchangeable potassium (K e ) . The mean K, rose from 1462 mmol in failure to 1705 mmol after recovery, 1637 to 1991 mmol in CP and 1286 to 1418 mmol in RHD. Values for K, related to DBW rose on recovery. The mean value for Ke/DBW rose from 74·3 mmol/kg in failure to 89·7 mmol/kg after recovery, 81·9 to 102·9 mmoljkg in CP and 66·7 to 76·4 mmol/kg in RHD.
Residual potassium (Res K). The mean Res K rose from 1390 mmol in failure to 1643 mmol after recovery, 1552 to 1923 mmol in CP, but only 1228 to 1362 mmol in RHD. ""Il DISCUSSION The study of a group of patients before and after treatment, as is described here, removes many of the difficulties of comparison of two or more separate groups since the only variables are within the patient.
It has been suggested (O'Meara, Birkenfeld, Gotch & Edelman, 1957 )that equilibration may not occur within 24 h in this type of study in patients with oedema. However, the problem of equilibration has been studied in detail by Flear, Cooke, Sivyer & Domenet (1963) with respect to the measurement of K e. These workers found that although delay in equilibration does sometimes occur, it was not related to the presence or absence of oedema. In our studies successiveestimates of Na, and K, at hourly intervals between 20 and 24 h after injection did not show any progressive increase, suggesting that equilibration had taken place.
In this study patients in CCF had an excess ofTBW and ECF in proportion to body weight compared with our control group and this excesswas less after treatment. The changes in TBW and ECFwith treatment were significant(P<O·OOl andP<0·05 respectively),and both changes approached the values in our control patients. Comparing TBW and ECF in CCF and controls as a percentage of body weight, there was no significant difference in TBW (P > 0,1), but there was a significant increase in ECF both before (P<0·005) and after treatment (P<O·OI), suggesting that even after apparent clinical recovery there was still an excess of ECF.
An increased Nae/DBW has previously been shown in patients with CCF secondary to chronic pulmonary disease. The value fell after treatment but not to values found in eight normal subjects (Cox, Davies-Jones & Leonard, 1964) . In this study Nae/DBW again fell with recovery but did not approach the value found in the control group (Table 2) .
Our results for K, agree with those of other workers in showing a decrease in heart failure (Flear et al., 1966) . In this study the Ke/DBW ratio increased significantly with recovery from heart failure to a value approximating closely to that in the control group.
Since nearly all body potassium is found in the cells a rise in K, of this order must be due to an increase in intracellular potassium concentration or to an increase in body cell mass. During the period of study there was no significant change in dry body weight, but Res Na and Res K, which are essentially intracellular sodium and potassium, were significantly altered during recovery from CCF: a fall in Res Na was accompanied by a rise in Res K while the sum of the two electrolytes remains effectively unchanged. These results seem to indicate movement of sodium into the cell and of potassium out of the cell in CCF which is reversed by successfultreatment. White, Chamberlain, Hamer, McAlister & Hawkins (1969) in a study of patients with treated cardiac failure who were free of oedema concluded that there was no significant intracellular alteration of potassium in chronic heart failure. In their opinion the major cause of the low exchangeable potassium was the loss of cell mass that occurs in chronic heart disease. Our findings in oedematous heart failure indicate that there is an additional significant loss of intracellular potassium.
